ACELYRIN, Inc. License Agreements
1 Contracts & Agreements
- License and Commercialization Agreement by and between ValenzaBio Inc. and Pierre Fabre Medicament SAS, dated March 25, 2021, as amended (Filed With SEC on April 13, 2023)
